microRNA-1/133a and microRNA-206/133b clusters: Dysregulation and functional roles in human cancers

Nijiro Nohata, Toyoyuki Hanazawa, Hideki Enokida and Naohiko Seki _

PDF  |  HTML  |  Supplementary Files  |  How to cite

Oncotarget. 2012; 3:9-21. https://doi.org/10.18632/oncotarget.424

Metrics: PDF 5260 views  |   HTML 4990 views  |   ?  


Nijiro Nohata1,2, Toyoyuki Hanazawa2, Hideki Enokida3, Naohiko Seki1

1 Department of Functional Genomics, Chiba University Graduate School of Medicine, Chiba, Japan

2 Department of Otorhinolaryngology/Head and Neck Surgery, Chiba University Graduate School of Medicine, Chiba, Japan

3 Department of Urology, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan

Received: January 25, 2012; Accepted: January 25, 2012; Published: February 4, 2012;

Keywords: cancer, miRNA, miR-1, miR-133a, miR-133b, miR-206


Naohiko Seki, email:


MicroRNAs (miRNAs) are endogenous short non-coding RNA molecules that regulate gene expression by repressing translation or cleaving RNA transcripts in a sequence-specific manner. A growing body of evidence suggests that miRNAs are aberrantly expressed in many human cancers and that they play significant roles in the initiation, development and metastasis of human cancers. Genome-wide miRNA expression signatures provide information on the aberrant expression of miRNAs in cancers rapidly and precisely. Recently, studies from our group and others revealed that microRNA-1 (miR-1), microRNA-133a (miR-133a), microRNA-133b (miR-133b) and microRNA-206 (miR-206) are frequently downregulated in various types of cancers. Interestingly, miR-1-1/miR-133a-2, miR-1-2/miR-133a-1, and miR-206/miR-133b form clusters in three different chromosomal regions of the human genome – 20q13.33, 18q11.2 and 6p12.1, respectively. Here we review highlights of recent findings on the aberrant expression and functional significance of the miR-1/miR-133a and miR-206/miR-133b clusters in human cancers.

Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 424